Literature DB >> 33547949

Using ultrasound-targeted microbubble destruction to enhance radiotherapy of glioblastoma.

Chanjuan Peng1,2, Yong Wu3,2, Yang Yang4,2, Ningning Li5,2, Xi Chen1,2, Linhui Gu6,2, Dong Xu7,8, Chen Yang9,10.   

Abstract

OBJECTIVE: To investigate the efficacy and mechanism of ultrasound-targeted microbubble destruction (UTMD) combined with radiotherapy (XRT) on glioblastoma.
METHODS: The enhanced radiosensitization by UTMD was assessed through colony formation and cell apoptosis in Human glioblastoma cells (U87MG). Subcutaneous transplantation tumors in 24 nude mice implanted with U87MG cells were randomly assigned to 4 different treatment groups (Control, UTMD, XRT, and UTMD + XRT) based on tumor sizes (100-300 mm3). Tumor growth was observed for 10 days after treatment, and then histopathology stains (HE, CD34, and γH2AX) were applied to the tumor samples. A TUNEL staining experiment was applied to detect the apoptosis rate of mice tumor samples. Meanwhile, tissue proteins were extracted from animal specimens, and the expressions of dsDNA break repair-related proteins from animal specimens were examined by the western blot.
RESULTS: When the radiotherapy dose was 4 Gy, the colony formation rate of U87MG cells in the UTMD + XRT group was 32 ± 8%, lower than the XRT group (54 ± 14%, p < 0.01). The early apoptotic rate of the UTMD + XRT group was 21.1 ± 3% at 48 h, higher than that of the XRT group (15.2 ± 4%). The tumor growth curve indicated that the tumor growth was inhibited in the UTMD + XRT group compared with other groups during 10 days of observation. In TUNEL experiment, the apoptotic cells of the UTMD + XRT group were higher than that of the XRT group (p < 0.05). The UTMD + XRT group had the lowest MVD value, but was not significantly different from other groups (p > 0.05). In addition, γH2AX increased due to the addition of UTMD to radiotherapy compared to XRT in immunohistochemistry (p < 0.05).
CONCLUSIONS: Our study clearly demonstrated the enhanced destructive effect of UTMD combined with 4 Gy radiotherapy on glioblastoma. This could be partly achieved by the increased ability of DNA damage of tumor cells.

Entities:  

Keywords:  Glioblastoma; Microbubbles; Radiation therapy; Ultrasound; Ultrasound therapy

Mesh:

Year:  2021        PMID: 33547949     DOI: 10.1007/s00432-021-03542-5

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  3 in total

1.  Non-invasive monitoring of ultrasound-stimulated microbubble radiation enhancement using photoacoustic imaging.

Authors:  K Briggs; A Al Mahrouki; J Nofiele; A El-Falou; M Stanisz; H C Kim; M C Kolios; G J Czarnota
Journal:  Technol Cancer Res Treat       Date:  2013-08-31

2.  Opening the Blood-Brain Barrier and Improving the Efficacy of Temozolomide Treatments of Glioblastoma Using Pulsed, Focused Ultrasound with a Microbubble Contrast Agent.

Authors:  Qian Dong; Lin He; Linbo Chen; Qiongzhen Deng
Journal:  Biomed Res Int       Date:  2018-11-11       Impact factor: 3.411

3.  Ultrasound Mediated Microbubbles Destruction Augmented Sonolysis: An In Vitro and In Vivo Study.

Authors:  Hai Cui; Qiong Zhu; Yunhua Gao; Hongmei Xia; Kaibin Tan; Ying He; Zheng Liu; Yali Xu
Journal:  Biomed Res Int       Date:  2017-08-16       Impact factor: 3.411

  3 in total
  3 in total

Review 1.  Application of Ultrasound Combined with Microbubbles for Cancer Therapy.

Authors:  Deepa Sharma; Kai Xuan Leong; Gregory J Czarnota
Journal:  Int J Mol Sci       Date:  2022-04-15       Impact factor: 6.208

2.  Ultrasound-triggered microbubble destruction enhances the radiosensitivity of glioblastoma by inhibiting PGRMC1-mediated autophagy in vitro and in vivo.

Authors:  Ying He; Xun-Hu Dong; Qiong Zhu; Ya-Li Xu; Ming-Liang Chen; Zheng Liu
Journal:  Mil Med Res       Date:  2022-02-14

Review 3.  Applications of Focused Ultrasound for the Treatment of Glioblastoma: A New Frontier.

Authors:  Andrew M Hersh; Meghana Bhimreddy; Carly Weber-Levine; Kelly Jiang; Safwan Alomari; Nicholas Theodore; Amir Manbachi; Betty M Tyler
Journal:  Cancers (Basel)       Date:  2022-10-08       Impact factor: 6.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.